课题基金 / 基金详情

X-linked Alport syndrome : Mutation survey over all 51 exons of the COL4A5 gene

X-linked Alport syndrome : Mutation survey over all 51 exons of the COL4A5 gene
X连锁Alport综合征:COL4A5基因全部51个外显子的突变调查
批准号:
07671249
负责人:
YOSHIKAWA Norishige
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

YOSHIKAWA Norishige的其他基金

相似基金

相关文献

中文摘要
翻译
Alport综合征是一种遗传性疾病,以进行性肾炎为特征,伴有肾小球基底膜(GBM)的超微结构编织改变和神经感觉性耳聋。最常见的X连锁Alport综合征是由编码IV型胶原α5链(alpha5(IV))的Col4A5基因突变引起的。一些研究小组已经对Col4A5基因的全部51个外显子进行了突变分析。然而,这些调查都是利用基因组DNA进行SSCP分析,突变的检测率不到50%。本研究采用逆转录-聚合酶链式反应(RT-PCR)技术对COL4A5基因的全部51个外显子进行突变检测,并用mRNA法进行直接测序,在所有男性患者和78%的女性患者中检测到突变。我们的结果有助于设计一种更好的策略来识别X连锁Alport综合征的突变,并促进基因型与表型的相关性。
英文摘要
Alport syndrome is an inherited disorder characterized by progressive nephritis with ultrastructural basket-weave changes of the glomerular basement membrane (GBM) and neurosensory deafness. The most frequent type, X-linked Alport syndrome is caused by mutations in the COL4A5 gene encoding the type IV collagen alpha5 chain (alpha5 (IV) ).Mutation analysis of all 51 exons of the COL4A5 gene has been performed by some groups. However, These surveys were performed by SSCP analysis using genomic DNA and the detection rate of mutations was less than 50%. In this study we performed mutation survey over all 51 exons of the COL4A5 gene by reverse transcription-polymerase chain reaction (RT-PCR) and direct sequence using mRNA.Mutations were detected in all male patients and 78% of female patients. Our result help in the design of a better strategy for mutation identification in X-linked Alport syndrome and facilitate genotype-phenotype correlations.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Kitagawa K,Nakanishi K,Iijima K,Nishio H,Sano K,Sado Y,Nakamura H,Yoshikawa N.: "Mutation in alpha5 (IV) collagen chain gene in nonfamilial hematuria." J Am soc Nephrol. 6. 264-268 (1995)
Kitakawa K、Nakanishi K、Iijima K、Nishio H、Sano K、Sado Y、Nakamura H、Yoshikawa N.:“非家族性血尿中 α5 (IV) 胶原链基因的突变。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakanishi,K: "Expression of type IV collagen α3 and α4 chain mRDAs in X-linked Alport syndrome" Journal American Society of Naphrology. (In press). (1996)
Nakanishi, K:“X 连锁 Alport 综合征中 IV 型胶原蛋白 α3 和 α4 链 mRDA 的表达”,美国肾脏病学会杂志(1996 年出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
吉川 徳茂: "遺伝性糸球体疾患" カレントテラピー. 15. 34-38 (1997)
Norishige Yoshikawa:“遗传性肾小球疾病”《当前疗法》15. 34-38 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakanishi K,Yoshikawa N,Iijima K,Nakamura H.: "Expression of type IV collagen alpha3 and alpha4 chain mRNAs in X-linked Alport syndrome." J Am soc Nephrol. 7. 938-945 (1996)
Nakanishi K、Yoshikawa N、Iijima K、Nakamura H.:“X 连锁 Alport 综合征中 IV 型胶原 α3 和 α4 链 mRNA 的表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 7 条
    Role of imflammasome in IgA nephropathy
    • 批准号:
      24390265
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2012
    • 负责人:
      YOSHIKAWA Norishige
    • 依托单位:
    Mutation analysis in Japanese patients with congenital and infantile nephritic syndrome
    • 批准号:
      21591396
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      YOSHIKAWA Norishige
    • 依托单位:
    Genetic analysis of glomerular podocyte molecules in children with nephrotic syndrome
    • 批准号:
      18591199
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.47万
    • 财政年份:
      2006
    • 负责人:
      YOSHIKAWA Norishige
    • 依托单位:
    Genetic analysis in children with Escherichia coli O157-associated hemolytic uremic syndrome
    • 批准号:
      15590855
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      YOSHIKAWA Norishige
    • 依托单位:
    海外基金